Publications by authors named "Frederic Doublet"

Claim this Profile
D
Discovery of JNJ-1802, a First-in-Class Pan-Serotype Dengue Virus NS4B Inhibitor.
Bart Kesteleyn, Jean-François Bonfanti, Dorothée Bardiot, Benoît De Boeck, Olivia Goethals, Frédéric Doublet

J Med Chem· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Acyl-Indole Derivatives as Pan-Serotype Dengue Virus NS4B Inhibitors.
Bart Kesteleyn, Dorothée Bardiot, Jean-François Bonfanti, Benoît De Boeck, Olivia Goethals, Frédéric Doublet

J Med Chem· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121).
Jean-François Bonfanti, Christophe Meyer, Frédéric Doublet, Jérôme Fortin, Philippe Muller

J Med Chem· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of a respiratory syncytial virus fusion inhibitor clinical candidate, part 1: improving the pharmacokinetic profile using the structure-property relationship.
Jean-François Bonfanti, Frédéric Doublet, Jérôme Fortin, Jean Lacrampe, Jérôme Guillemont

J Med Chem· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis